Skip to main content
. 2019 Jun 25;58(11):1355–1371. doi: 10.1007/s40262-019-00790-0

Box 6.

Resolving parameter non-identifiability through hypothesis testing with PBPK simulations: identifying gut metabolism (reference 43). PBPK physiologically based pharmacokinetics, NCE new chemical entity, CYP cytochrome P450, IV intravenous, PK pharmacokinetics, SAD single ascending dose, MAD multiple ascending dose, DDI drug–drug inhibition, Fg gut bioavailability,  CLint intrinsic clearance, P-gp P-glycoprotein, Kp tissue partition coefficient

graphic file with name 40262_2019_790_Tab8_HTML.jpg